Australia's CSL Ltd said it's evaluating whether its drugs used in surgery would be exempted from 125% tariffs China imposed ...

InVitria, a leading developer of recombinant, chemically defined components for biomanufacturing, has announced the launch of Optibumin® 25, the first and only recombinant human serum albumin (rHSA) ...

TNX-1700 is in preclinical development for gastric and colorectal cancers ...

NEW YORK] China has asked some of its state-owned drugmakers to study how they can reduce reliance on the US for pharmaceutical products and raw materials, sources familiar with the matter said, as ...

Travere Therapeutics, Inc., and CSL Vifor are pleased to announce that the European Commission has approved the conversion of the conditional marketing approval (CMA) into a standard marketing ...

Bazedoxifene and conjugated estrogens may offer a safer, more effective alternative to tamoxifen for overweight women at high risk of breast cancer. Metabolic and transcriptional effects of ...